Skip to content
Homepage
Author:
RadioMedix, Inc.
Posted Date:
June 10, 2026
RadioMedix Announces Receiving FDA Approval of its Generic Ga-68 PSMA-11 Radiodiagnostic for Prostate Cancer
RadioMedix, Inc.
June 10, 2026
RadioMedix to Present at SNMMI 2026 and Mark 20 Years of Radiopharmaceutical Innovation
RadioMedix, Inc.
May 28, 2026
